Complete Filing Data
ESG Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $11.85 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ESG Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$1.9M | $944.6K | -$324.7K | -$54.9K | -$1.5K |
| Revenue * | $6.1M | $12.7M | $7.5M | ||
| Operating Income Loss | -$2.2M | $1.7M | -$209.7K | -$55.0K | -$1.5K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.5M | $1.2M | -$392.2K | -$54.9K | -$1.5K |
| Research And Development Expense | $362.5K | $708.8K | $609.7K | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $400.4K | -$281.1K | -$281.6K | ||
| Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest | -$136.9K | $96.1K | $96.3K | ||
| Net Income Loss Attributable To Noncontrolling Interest | -$555.9K | $303.2K | -$67.5K | ||
| Gross Profit | $517.5K | $3.5M | $1.8M | ||
| Cost Of Revenue | $5.6M | $9.1M | $5.7M | ||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$419.0K | $207.1K | -$163.8K | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest | -$377.2K | -$377.9K | |||
| Other Nonoperating Income Expense | $271.1K | $213.3K | $230.6K | ||
| General And Administrative Expense | $37.9K | $55.0K | $1.5K | ||
| Comprehensive Income Net Of Tax | -$1.5M | $663.6K | -$606.3K | ||
| Net Income Loss Available To Common Stockholders Basic | -$2.5M | $1.2M | $54.9K | $1.5K | |
| Operating Expenses | $2.8M | $1.9M | $2.0M | $55.0K | $1.5K |
| Nonoperating Income Expense | -$253.6K | -$439.8K | -$182.5K | ||
| Interest Expense | |||||
| Interest Income Expense Nonoperating Net | -$524.7K | -$653.1K | -$413.2K | ||
| Selling General And Administrative Expense | $2.4M | $1.2M | $1.4M | ||
| Deferred Revenue Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.3M | $517.6K | -$212.7K | $22.7K | $81.3K | -$587.7K | $45.7K | $56.6K | -$142.3K | -$7.5K | -$556.00 | -$28.1K | -$22.4K | |
| Revenue * | $491.3K | $2.5M | $1.6M | $2.2M | $2.5M | $2.4M | $518.2K | $3.6M | $1.8M | |||||
| Operating Income Loss | -$1.7M | $806.4K | -$274.7K | $122.0K | $155.9K | -$540.0K | -$17.7K | $205.5K | -$60.6K | -$7.5K | -$565.00 | -$28.1K | -$22.4K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.7M | $696.4K | -$276.2K | -$3.5K | $104.3K | -$785.5K | $74.5K | $81.2K | -$182.4K | -$7.5K | -$556.00 | -$28.1K | -$22.4K | |
| Research And Development Expense | $139.8K | $155.1K | $66.3K | $144.6K | $128.7K | $131.1K | $152.8K | $174.3K | $130.2K | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $141.5K | $129.6K | $291.9K | $162.0K | -$8.0K | -$159.6K | -$191.1K | -$414.0K | $43.1K | |||||
| Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest | -$48.4K | -$44.3K | -$99.8K | -$55.4K | $2.7K | $54.6K | $65.3K | $141.6K | -$14.7K | |||||
| Net Income Loss Attributable To Noncontrolling Interest | -$390.5K | $178.8K | -$63.5K | -$26.2K | $23.0K | -$197.8K | $28.8K | $24.6K | -$40.1K | |||||
| Gross Profit | -$932.2K | $1.1M | $80.9K | $508.6K | $432.2K | -$90.6K | $416.3K | $703.3K | $343.0K | |||||
| Cost Of Revenue | $1.4M | $1.4M | $1.5M | $1.7M | $2.1M | $2.5M | $101.9K | $2.9M | $1.5M | |||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$342.1K | $223.2K | $36.3K | $29.2K | $20.2K | -$252.4K | -$36.5K | -$116.9K | -$25.4K | |||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest | $189.9K | $174.0K | $391.7K | $217.4K | -$10.8K | -$214.1K | -$256.4K | -$555.5K | $57.8K | |||||
| Other Nonoperating Income Expense | $94.1K | $23.9K | $129.0K | -$181.00 | $80.5K | -$96.0K | $27.8K | |||||||
| General And Administrative Expense | $239.7K | $145.3K | $318.2K | $280.0K | $323.2K | $273.1K | $7.5K | $565.00 | $28.1K | $22.4K | ||||
| Comprehensive Income Net Of Tax | -$1.2M | $647.2K | $79.2K | $184.7K | $73.3K | -$747.2K | -$99.3K | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$1.7M | $696.4K | -$276.2K | -$3.5K | $104.3K | -$785.5K | $74.5K | $81.2K | -$182.4K | $7.5K | $22.4K | |||
| Operating Expenses | $747.4K | $276.0K | $355.7K | $386.5K | $276.3K | $449.4K | $12.4K | $403.6K | $7.5K | $565.00 | $28.1K | $22.4K | ||
| Nonoperating Income Expense | -$32.8K | -$110.0K | -$1.4K | -$125.6K | -$51.6K | -$245.5K | -$121.9K | |||||||
| Interest Expense | $125.4K | $132.1K | -$62.6K | $200.0K | ||||||||||
| Interest Income Expense Nonoperating Net | -$127.0K | -$133.9K | -$130.4K | -$125.4K | -$132.1K | -$149.5K | -$149.7K | |||||||
| Selling General And Administrative Expense | $607.6K | $120.9K | $289.3K | $241.9K | $147.6K | $318.3K | ||||||||
| Deferred Revenue Current | $1.3M | $1.3M | $1.3M | $1.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $8.8M | $10.3M | $9.6M | $83.8K | $138.6K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $79.9K | $166.7K | $342.3K | $206.6K | $127.6K |
| Retained Earnings Accumulated Deficit | -$2.1M | -$168.6K | -$93.9K | -$56.4K | -$1.5K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$86.9K | -$175.6K | $135.7K | -$41.5K | $127.6K |
| Liabilities And Stockholders Equity | $26.9M | $29.8M | $26.3M | $87.2K | $138.6K |
| Common Stock Value | $25.9K | $25.9K | $25.9K | $15.5K | $15.4K |
| Assets Current | $6.8M | $7.0M | $2.2M | $86.1K | $138.6K |
| Assets | $26.9M | $29.8M | $26.3M | $87.2K | $138.6K |
| Property Plant And Equipment Net | $16.3M | $17.2M | $18.7M | $1.0K | $0.00 |
| Accounts Payable Current | $1.5M | $4.6M | $1.0K | $3.4K | |
| Liabilities Current | $13.1M | $13.8M | $10.7M | $3.4K | |
| Liabilities | $15.1M | $16.0M | $13.3M | $3.4K | |
| Minority Interest | $3.1M | $3.5M | $3.3M | ||
| Value Added Tax Receivable Noncurrent | $838.3K | $2.7M | $2.2M | ||
| Other Accrued Liabilities Current | $5.0M | $3.1M | $2.3M | ||
| Longterm Payable Noncurrent | $960.8K | $1.1M | $1.4M | ||
| Inventory Net | $112.3K | $2.9M | $1.7M | ||
| Assets Noncurrent | $20.1M | $22.8M | $24.0M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$310.9K | -$711.3K | -$430.2K | ||
| Liabilities Noncurrent | $2.0M | $2.2M | $2.7M | ||
| Cash And Cash Equivalents At Carrying Value | $6.4K | $86.1K | $127.6K | ||
| Finite Lived Intangible Assets Net | $3.0M | $2.9M | $3.1M | ||
| Accounts And Other Receivables Net Current | $3.2M | $2.9M | |||
| Note Receivable Noncurrent | $41.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $9.8M | $11.0M | $10.4M | $9.0M | $8.8M | $8.8M | $12.8M | $61.9K | $74.2K | $76.3K | $87.7K | $88.3K | $116.3K | $138.6K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $109.2K | $129.4K | $177.6K | $444.8K | $135.2K | $833.1K | $165.1K | $206.6K | $564.0K | $80.8K | $86.6K | $87.1K | $115.1K | ||
| Retained Earnings Accumulated Deficit | -$1.2M | $136.3K | -$381.3K | -$1.7M | -$1.7M | -$1.8M | $1.1M | -$78.3K | -$65.9K | -$63.9K | -$52.4K | -$51.9K | -$23.8K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $10.8K | $490.7K | $357.4K | -$5.4K | -$12.5K | ||||||||||
| Liabilities And Stockholders Equity | $27.6M | $29.3M | $28.7M | $27.1M | $26.9M | $25.3M | $66.0K | $75.2K | $81.7K | $87.7K | $88.3K | $116.3K | |||
| Common Stock Value | $25.9K | $25.9K | $25.9K | $25.9K | $25.9K | $25.9K | $15.5K | $15.5K | $15.5K | $15.5K | $15.5K | $15.4K | |||
| Assets Current | $7.3M | $6.7M | $6.0M | $3.7M | $3.9M | $2.1M | $65.1K | $74.3K | $80.8K | $86.6K | $87.1K | $115.1K | |||
| Assets | $27.6M | $29.3M | $28.7M | $27.1M | $26.9M | $25.3M | $66.0K | $75.2K | $81.7K | $87.7K | $88.3K | $116.3K | |||
| Property Plant And Equipment Net | $16.5M | $16.8M | $16.9M | $17.9M | $17.8M | $17.9M | $834.00 | $899.00 | $964.00 | $1.1K | $1.2K | $1.2K | |||
| Accounts Payable Current | $3.0M | $1.5M | $1.8M | $2.7M | $3.0M | $1.3M | $1.3M | $4.1K | $1.0K | $5.4K | |||||
| Liabilities Current | $12.3M | $12.4M | $12.6M | $13.7M | $13.7M | $12.2M | $4.1K | $1.0K | $5.4K | ||||||
| Liabilities | $14.3M | $14.5M | $14.8M | $15.0M | $15.0M | $13.5M | $4.1K | $1.0K | $5.4K | ||||||
| Minority Interest | $3.4M | $3.8M | $3.6M | $3.1M | $3.0M | $3.0M | |||||||||
| Value Added Tax Receivable Noncurrent | $893.5K | $2.9M | $2.8M | $2.4M | $2.3M | $2.2M | |||||||||
| Other Accrued Liabilities Current | $2.9M | $4.8M | $4.7M | $2.7M | $2.5M | $2.4M | |||||||||
| Longterm Payable Noncurrent | $998.6K | $1.0M | $1.1M | $1.3M | $1.3M | $1.4M | |||||||||
| Inventory Net | $1.3M | $2.1M | $2.4M | $1.9M | $2.2M | $718.2K | |||||||||
| Assets Noncurrent | $20.3M | $22.6M | $22.7M | $23.4M | $23.0M | $23.2M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$148.3K | -$289.7K | -$419.4K | -$435.8K | -$597.8K | -$589.8K | |||||||||
| Liabilities Noncurrent | $2.0M | $2.1M | $2.1M | $1.3M | $1.4M | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $444.8K | $135.2K | $833.1K | $342.3K | $5.1K | $14.3K | $80.8K | $86.6K | $87.1K | $115.1K | |||||
| Finite Lived Intangible Assets Net | $3.0M | $3.0M | $2.9M | $3.0M | |||||||||||
| Accounts And Other Receivables Net Current | $3.3M | $3.6M | $2.5M | $210.5K | $149.4K | $202.7K | $79.2K | ||||||||
| Note Receivable Noncurrent | $41.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $101.2K | $1.5M | $119.9K | -$40.2K | -$12.4K |
| Depreciation Depletion And Amortization | $1.8M | $1.8M | $1.5M | ||
| Increase Decrease In Inventories | -$2.8M | $1.3M | $523.7K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$898.7K | -$5.7K | $360.1K | ||
| Increase Decrease In Accounts And Other Receivables | $306.2K | $3.0M | |||
| Net Cash Provided By Used In Financing Activities | $888.8K | -$1.0M | -$344.4K | $140.0K | |
| Increase Decrease In Accounts Payable | -$3.1M | $3.4M | $217.3K | $3.4K | |
| Increase Decrease In Advance To Suppliers | $101.1K | $584.2K | $58.1K | ||
| Increase Decrease In Value Added Tax Receivable | -$238.4K | -$562.2K | $28.5K | ||
| Net Cash Provided By Used In Investing Activities | -$178.2K | -$685.1K | -$40.0K | -$1.3K | |
| Proceeds From Loans | $1.1M | $7.3M | $7.0M | ||
| Payments For Loans | $134.9K | $293.1K | |||
| Increase Decrease In Notes Receivables | -$41.4K | -$17.0K | |||
| Increase Decrease In Deferred Revenue | |||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | |||||
| Increase Decrease In Notes Payable Related Parties | -$30.0K | $8.7K | |||
| Payments To Acquire Property Plant And Equipment | $178.2K | $685.1K | $1.3K | ||
| Increase Decrease In Other Accounts Payable | $828.2K | -$469.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.6M | $95.0K | $498.5K | -$5.4K | -$28.0K | -$11.3K |
| Depreciation Depletion And Amortization | $456.9K | $453.3K | $471.6K | $64.00 | ||
| Increase Decrease In Inventories | -$520.1K | -$933.2K | -$476.9K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $307.9K | $257.3K | -$141.1K | |||
| Increase Decrease In Accounts And Other Receivables | -$451.0K | $123.4K | $112.4K | |||
| Net Cash Provided By Used In Financing Activities | $1.4M | $138.5K | ||||
| Increase Decrease In Accounts Payable | -$2.8M | -$147.8K | -$286.9K | $2.1K | ||
| Increase Decrease In Advance To Suppliers | $228.7K | -$58.5K | ||||
| Increase Decrease In Value Added Tax Receivable | $21.2K | $8.2K | ||||
| Net Cash Provided By Used In Investing Activities | -$88.3K | -$1.3K | ||||
| Proceeds From Loans | $138.5K | |||||
| Payments For Loans | ||||||
| Increase Decrease In Notes Receivables | -$706.00 | $250.00 | ||||
| Increase Decrease In Deferred Revenue | -$62.5K | -$97.6K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $64.5K | $132.9K | ||||
| Increase Decrease In Notes Payable Related Parties | -$30.0K | $30.0K | ||||
| Payments To Acquire Property Plant And Equipment | $88.3K | $1.3K | ||||
| Increase Decrease In Other Accounts Payable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | $0.04 | -$0.02 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 25.9M | 25.9M | 25.9M | 15.5M | |
| Earnings Per Share Basic | $-0.02 | $0.04 | $-0.02 | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 25.9M | 25.9M | 25.9M | 15.5M | |
| Common Stock Shares Outstanding | 25.9M | 25.9M | 25.9M | 15.5M | 15.5M |
| Common Stock Shares Issued | 25.9M | 25.9M | 25.9M | 15.5M | 15.5M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | $0.01 | -$0.01 | $0.01 | $0.00 | -$0.02 | -$0.01 | -$0.01 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 15.4M | |||
| Earnings Per Share Basic | $-0.02 | $0.01 | $-0.01 | $0.01 | $0.00 | $-0.02 | $-0.01 | $-0.01 | $0.00 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | 25.9M | ||||
| Common Stock Shares Outstanding | 25.9M | 25.9M | 25.9M | 15.5M | 15.5M | 15.5M | 15.5M | 15.5M | 15.4M | ||||
| Common Stock Shares Issued | 25.9M | 25.9M | 25.9M | 15.5M | 15.5M | 15.5M | 15.5M | 15.5M | 15.4M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Additional Paid In Capital | $200.0K | $11.2M | $11.2M | $11.2M | $124.7K | $124.7K |
| Supplies | $837.2K | $736.1K | $166.0K | |||
| Selling Expense | ||||||
| Interest Paid Net | $332.0K | $413.2K | ||||
| Bank Loans |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $11.2M | $11.2M | $11.2M | $11.2M | $11.2M | $11.2M | $124.7K | $124.7K | $124.7K | $124.7K | $124.7K | $124.7K | ||
| Supplies | $209.0K | $494.5K | $645.4K | $1.2M | $1.4M | $394.7K | ||||||||
| Selling Expense | $2.3K | $2.3K | $199.00 | $1.3K | $377.00 | $223.00 | ||||||||
| Interest Paid Net | $76.6K | $150.4K | $142.5K | |||||||||||
| Bank Loans | $6.9M | $6.9M | $7.2M | $6.9M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.